Accenture and Endgame Form Alliance to Help Organizations Hunt, Block and Remove Cyber Adversaries

Accenture (NYSE: ACN) formed a new alliance relationship with Endgame Inc. – a provider of cybersecurity software solutions to actively hunt adversaries – to integrate the company’s sophisticated capabilities with Accenture’s cyber defense services. As part of the relationship, Accenture has also taken an equity position in Endgame. Terms of the investment were not disclosed.

The Dark Net: Policing the Internet’s Underworld

By Sir David Omand First published in the World Policy Journal Winter 2015/2016 LONDON—In 1910, one of the last remaining bands of outlaws of America’s Wild West emerged from their hideout in the Sierra Ladrones Mountains in New Mexico and …

Digital Shadows Announces $14 Million Series B Funding Raise

Digital Shadows, the only company to offer organizations cyber situational awareness, today announced that it has closed its Series B funding at $14 million, led by Trinity Ventures, with general partner Fred Wang joining the company’s Board of Directors. Existing investors Storm Ventures, TenEleven Ventures and Passion Capital also participated, and the company also welcomed new investor Paladin Capital Group.

Twist Bioscience Completes $61 Million Series D Financing and $20 Million Debt Facility

Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the completion of a $61 million Series D private financing. Crossover participants in the round include ARCH Overage Fund, Merieux Developpement, Cormorant Asset Management LLC, Fidelity Management and Research Company and Foresite Capital Management LLC. Additional investors include ARCH Venture Partners, WuXi Healthcare Ventures, Illumina, Inc., Nick and Joby Pritzker (through their family’s firm Tao Invest), Paladin Capital Group, Yuri Milner, Boris Nikolic and additional strategic corporate and venture investors.

Emily Leproust Of Twist Bioscience Named 2015 Global Thinker By Foreign Policy Magazine

Twist Bioscience, a company focused on synthetic DNA, today announced that its CEO, Emily Leproust, Ph.D., has been selected as one of Foreign Policy’s 100 Leading Global Thinkers of 2015 for fast-tracking the building blocks of life. Each year, Foreign Policy selects the leading Global Thinkers whose contributions and work have changed lives and are shaping the world.

ProtectWise Raises $20 Million In Series B

ProtectWise, provider of the industry’s first Cloud Network DVR for complete detection, visibility and response to enterprise threats, today announced it has closed its Series B round of funding of $20 million. In total, the company has raised more than $37 million dollars in venture capital funding since May 2013. The new funding will be used to support the company’s continued growth, technology innovation and market expansion.

Page 20 of 26« First...10...1819202122...Last »